Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 8421-8430 of 13616

Page
per page
  1. BI-3406
    C9081 BI-3406
    Summary: A KRASSOS1 inhibitor for RAS pathway research, with nanomolar in vitro activity.
  2. Ziprasidone hydrochloride monohydrate
    A3953 Ziprasidone hydrochloride monohydrate
    Summary: 5-HT (serotonin)/dopamine receptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥11.69 mg/mL
  3. NCH 51
    A4495 NCH 51
    Summary: Histone deacetylase (HDAC) inhibitor
  4. 1,2,3,4,5,6-Hexabromocyclohexane
    A4510 1,2,3,4,5,6-Hexabromocyclohexane
    Summary: JAK2 tyrosine kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥8.22 mg/mL
  5. Sunitinib malate
    A8255 Sunitinib malate
     5 Citation
    Target: VEGFR
    Summary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor
      ≥26.65 mg/mL
  6. Neratinib (HKI-272)
    A8322 Neratinib (HKI-272)
     3 Citation
    Target: EGFR
    Summary: HER2/EGFR inhibitor,potent and irreversible
      insoluble in H2O; ≥13.93 mg/mL
  7. A66
    A8354 A66
    Target: PI3K
    Summary: P110α inhibitor
      insoluble in H2O; ≥19.7 mg/mL
  8. Bephenium Hydroxynaphthoate
    A8376 Bephenium Hydroxynaphthoate
    Summary: Anthelmintic agent
      insoluble in H2O; insoluble in EtOH; ≥20.85 mg/mL
  9. Deferasirox
    A8639 Deferasirox
     3 Citation
    Summary: Oral iron chelator
      insoluble in H2O; ≥37.28 mg/mL
  10. Capecitabine
    A8647 Capecitabine
    Summary: DNA, RNA and protein synthesis inhibitor
      ≥10.97 mg/mL

Items 8421-8430 of 13616

Page
per page